Open access
Open access
Powered by Google Translator Translator

Hepatology

Phase 2 single-arm study: Fazirsiran for liver disease associated with Alpha1-Antitrypsin deficiency.

27 Jun, 2022 | 11:19h | UTC

Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency – New England Journal of Medicine (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019.

27 Jun, 2022 | 11:17h | UTC

Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 – The Lancet Gastroenterology & Hepatology

Commentary: Chronic Hepatitis B Infections Decreasing in Recent Years – HCP Live

 

Commentary on Twitter

 


Guideline review: EASL clinical practice guidelines: drug-induced liver injury.

22 Jun, 2022 | 11:27h | UTC

Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI) – Frontline Gastroenterology

Original Article: EASL Clinical Practice Guidelines: Drug-induced liver injury – Journal of Hepatology

 


Stay Updated in Your Specialty

No spam, just news.